Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
79.00
-0.67 (-0.84%)
Jan 16, 2026, 4:00 PM EST - Market closed
Alcon Revenue
Alcon had revenue of $2.61B in the quarter ending September 30, 2025, with 6.52% growth. This brings the company's revenue in the last twelve months to $10.19B, up 4.34% year-over-year. In the year 2024, Alcon had annual revenue of $9.91B with 4.82% growth.
Revenue (ttm)
$10.19B
Revenue Growth
+4.34%
P/S Ratio
3.84
Revenue / Employee
$397,867
Employees
25,599
Market Cap
39.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
| Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
| Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
| Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
| Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
| Dec 31, 2019 | 7.51B | 355.00M | 4.96% |
| Dec 31, 2018 | 7.15B | 361.00M | 5.32% |
| Dec 31, 2017 | 6.79B | 200.00M | 3.03% |
| Dec 31, 2016 | 6.59B | -161.00M | -2.38% |
| Dec 31, 2015 | 6.75B | -426.00M | -5.93% |
| Dec 31, 2010 | 7.18B | 680.00M | 10.46% |
| Dec 31, 2009 | 6.50B | 205.00M | 3.26% |
| Dec 31, 2008 | 6.29B | 695.00M | 12.41% |
| Dec 31, 2007 | 5.60B | 702.40M | 14.34% |
| Dec 31, 2006 | 4.90B | 528.10M | 12.09% |
| Dec 31, 2005 | 4.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ALC News
- 4 days ago - Alcon Inc. (ALC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 11 days ago - Alcon Terminates Agreement to Acquire STAAR Surgical - Business Wire
- 11 days ago - STAAR Surgical Merger With Alcon Fails After Shareholders Vote No - Benzinga
- 12 days ago - Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon - Business Wire
- 12 days ago - Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing - Reuters
- 18 days ago - Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 weeks ago - Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon - Business Wire
- 4 weeks ago - Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders - Business Wire